Indivior Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:INDV) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -315 M36 M-27 M -111 M Cash from investing activities -98 M69 M-66 M -80 M Cash from financing activities -46 M-102 M-30 M -6 M Free cash flow -315 M36 M-27 M -111 M

News

Broadcom Inks Pact With Meta, Leads 21 Top Performers Onto Best Stock Watchlists

Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists

MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines

ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome

Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable

Bull of the Day: Neurocrine Biosciences (NBIX)

IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati

Kymera Jumps 17% on Early Enrollment Completion in Skin Disease Study

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker

IBD 50 Stock Indivior Breaks Out Amid Big Fund Ownership Expansion, Strong Profit Prospects

Reasons Why Investors Should Consider Betting on Indivior Stock

5 Small Drug Stocks to Invest in Amid a Biotech Comeback